Αρχική World News FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma World News FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma Από Ogkologos - 22 Αυγούστου, 2025 772 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on results from the ONC006, ONC013, ONC014, ONC016 and ONC018 studies Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Beloved Kindergarten Teacher Who Inspired Her Community Dies of Breast Cancer... 8 Απριλίου, 2021 A New Era of Early Cancer Detection With Blood Test May... 11 Σεπτεμβρίου, 2022 Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο 25 Ιανουαρίου, 2020 FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell... 3 Δεκεμβρίου, 2024 Φόρτωση περισσοτέρων HOT NEWS A coming together of minds for early detection Alcohol Tied to 750,000 Cancer Cases Worldwide in 2020 Living With Stage 4 Lung Cancer: How Genomic Testing Is Helping... Cancer clinical trials – learning lessons from the COVID-19 pandemic